Peter Jüni

Biographic Data

ID3467116
NAMEPeter Jüni
GIVEN NAMESPeter
FAMILY NAMEJüni
SIGNATUREJÜNI P
AFFILIATIONSSt. Michael's Hospital
ORCID0000-0002-5985-0670
VERIFIEDYes
TOTAL WORKS11
TOTAL CITATIONS1
AUTHOR COUNT11
EDITOR COUNT0
FIRST PUBLICATION YEAR2011
LATEST PUBLICATION YEAR2026
H-INDEX1

  • Gendered Paths To Cancer Knowledge and Screening Behavior among Black Adults

    Open AccessCarolyn M Tucker, Guillermo M Wippold et al.ARTICLEJournal of Racial and Ethnic…2026References: 49

    Efforts are needed to promote cancer knowledge and the uptake of cancer screening behaviors among Black Americans. Such efforts must be customized for the unique differences in facilitators/barriers among Black men and women. The present study leverages the potential of the UF Health Cancer Institute Community-Partnered Cancer Disparities Research Collaborative (CDRC) to identify the psychosocial and structural factors associated with cancer know…

  • Seroprevalence of Sars-CoV-2 antibodies among children receiving primary care in Toronto, Ontario

    Open AccessMary Aglipay, Jeffrey C Kwong et al.ARTICLECanadian Journal of Public Health2024Cited by: 1References: 14

  • Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years

    Open AccessNavindra Persaud, Nav Persaud et al.ARTICLEJAMA Health Forum2023

    ClinicalTrials.gov Identifier: NCT02744963

  • Design details for overdose education and take‐home naloxone kits

    Open AccessBenjamin Demott, Kate Sellen et al.ARTICLEHealth Expectations2022

    The codesign process was deliberately structured to involve community members (the public), with multiple opportunities for public contribution. In addition, patient/public participation was a principle for the management and structuring of the research team

  • Public health preventive measures and child health behaviours during Covid-19

    Open AccessXuedi Li, Leigh M Vanderloo et al.ARTICLECanadian Journal of Public Health2021References: 30

    Public health preventive measures during COVID-19 were associated with a negative impact on the health behaviours of Canadian children living in a large metropolitan area

  • Whole milk compared with reduced-fat milk and childhood overweight

    Open AccessShelley M Vanderhout, Mary Aglipay et al.ARTICLE2020

  • RoB 2

    Open AccessJonathan Sterne, Jelena Savović et al.ARTICLEBMJ2019

    Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.

  • ESC/ESH Guidelines for the management of arterial hypertension

    Open AccessBryan Williams, Giuseppe Mancia et al.ARTICLEEuropean Heart Journal2018

    The current background information and detailed discussion of the data can be found in ESC CardioMed - Section 44 Systemic hypertension ... ... Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily pr…

  • Robins-I

    Open AccessJonathan Sterne, Jonathan AC Sterne et al.ARTICLEBMJ2016

    Non-randomised studies of the effects of interventions are critical to many areas of healthcare evaluation, but their results may be biased. It is therefore important to understand and appraise their strengths and weaknesses. We developed ROBINS-I (“Risk Of Bias In Non-randomised Studies - of Interventions”), a new tool for evaluating risk of bias in estimates of the comparative effectiveness (harm or benefit) of interventions from studies that d…

  • Long-Term Comparison of Everolimus- and Sirolimus-Eluting Stents in Patients With Acute Coronary Syndromes

    Open AccessG Rex Smith, Bindu Kalesan et al.ARTICLEJACC: Cardiovascular Interventions2012

    Among patients with ACS, the unrestricted use of EES is associated with improved clinical outcome compared with SES during long-term follow-up to 3 years. Notably, the risk of stent thrombosis was lower among EES-treated ACS patients.

  • The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

    Open AccessJulian P T Higgins, D G Altman et al.ARTICLEBMJ2011

    Flaws in the design, conduct, analysis, and reporting of randomised trials can cause the effect of an intervention to be underestimated or overestimated. The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate